However, many more new checkpoints are being discovered beyond the PD-1/PD-L1 pair and CTLA4, and these newly discovered checkpoints54 need to be reexamined for their effect on atherosclerosis in the future to fully understand the relationship between tolerance-directed therapies in cancer versus atherosclerosis. The gene discussed is CTLA4; the disease is cancer.